CompletedNot Applicable

Reducing the Duration of Untreated Psychosis in the United States

United States94 participantsStarted 2018-02-19

Plain-language summary

The goal of this project is to investigate whether a systematic screening approach for individuals with first episode psychosis (FEP) can substantially reduce Duration of Untreated Psychosis (DUP). The study team will evaluate the feasibility of screening a consecutive help-seeking population entering mental health services in order to facilitate early identification of FEP cases, rapid referral to specialty care and engagement in treatment.

Who can participate

Age range12 Years – 30 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age 12- 30 * ability to participate in assessments in English * ability to provide informed consent (assent for those under age 18) * meet criteria for psychosis or psychosis risk on SIPS Exclusion Criteria: * previous diagnosis of schizophrenia or schizoaffective disorder.

What they're measuring

Duration of Untreated Psychosis (DUP)

Timeframe: Day 1

Trial details

NCT IDNCT03369730

SponsorIcahn School of Medicine at Mount Sinai

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-09-15

View on ClinicalTrials.gov More First Episode Psychosis (FEP) trials